Publicaciones en las que colabora con MARIA CONCEPCION PAYARES HERRERA (12)

2023

  1. Longer intervals between SARS-CoV-2 infection and mRNA-1273 doses improve the neutralization of different variants of concern

    Journal of medical virology, Vol. 95, Núm. 3, pp. e28679

2022

  1. Nurses competence in the reporting of medication-related incidents: An intervention study

    Nursing Open, Vol. 9, Núm. 6, pp. 2836-2846

2021

  1. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

    Journal of Clinical Investigation, Vol. 131, Núm. 20

  2. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

    Trials

  3. Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial

    Trials, Vol. 22, Núm. 1

  4. Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study

    BMC Medicine, Vol. 19, Núm. 1

  5. The EMA assessment of avapritinib in the treatment of gastrointestinal stromal tumours harbouring the PDGFRA D842V mutation

    ESMO Open, Vol. 6, Núm. 3

2020

  1. A retrospective controlled cohort study of the impact of glucocorticoid treatment in SARS-CoV-2 infection mortality

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 9

  2. Docencia de la farmacología clínica en tiempos de pandemia: Limitaciones y oportunidades de innovación docente

    Actas del II Congreso Internacional de Innovación Docente e Investigación en Educación Superior: avanzando en las Áreas de Conocimiento: 11, 12 y 13 de noviembre de 2020

  3. EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma

    Oncologist, Vol. 25, Núm. 12, pp. 1067-1074

2018

  1. A multicentric, open-label, randomized, comparative clinical trial of two different doses of expanded hbm-mscs plus biomaterial versus iliac crest autograft, for bone healing in nonunions after long bone fractures: Study protocol

    Stem Cells International, Vol. 2018

  2. Conocimiento sobre biosimilares en Atención Primaria: un estudio de la Sociedad Española de Médicos de Atención Primaria (SEMERGEN)

    Semergen: revista española de medicina de familia, Núm. 6, pp. 380-388